Related Experiment Video
Updated: Aug 5, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions
Kendra Wilson1, Jesus Salvador Flores Banda2, Sanjana Bukkapatnam3
1Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Texas at Tyler School of Medicine, 11937 US-271, Tyler, TX 75708, USA.
Therapeutic cancer vaccines show promise in immunotherapy but have variable efficacy. Combining these vaccines with other treatments, like immune checkpoint inhibitors, is key for future success.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Therapeutic cancer vaccines aim to harness the immune system against cancer.
- Clinical efficacy of current vaccine platforms is inconsistent.
- Understanding factors influencing vaccine response is crucial.
Purpose of the Study:
- To review clinical trials of major therapeutic cancer vaccine modalities.
- To evaluate safety, immunogenicity, and clinical outcomes.
- To identify factors affecting efficacy across diverse tumor types.
Main Methods:
- Systematic review of completed clinical trials.
- Analysis of peptide-based, nucleic acid--based, dendritic cell, whole cell, and vector-based vaccines.
- Focus on safety, immunogenicity, and clinical outcomes.
Main Results:
- Therapeutic cancer vaccines generally have a favorable safety profile.
- Monotherapy clinical efficacy has been limited.
- Outcomes vary by vaccine platform, tumor type, antigen choice, and tumor microenvironment (TME).
Conclusions:
- Advances in antigen design and combination strategies are improving vaccine roles in oncology.
- Optimizing integration with standard treatments, especially immune checkpoint inhibitors, is essential for future progress.
- Therapeutic cancer vaccines hold potential but require strategic implementation.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

